Family Medicine Doctors in Fairhaven, MA Accepting Medicare

5 Family Medicine doctors found. Showing 1 - 5

Dr. Valentina Dacunha, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-996-1800    Fax: 508-992-7906

Dr. Joseph A Costa, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-758-3781    Fax: 508-758-4455

Jaimie L. Reed, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-758-3781    Fax: 508-758-4455

Dr. Drew L Nahigyan, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 208 Mill Rd, Fairhaven, MA 02719 Phone: 508-758-3781    Fax: 508-758-4455

Sandra Diane Johnson, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 208 Mill Road, Fairhaven, MA 02719 Phone: 508-973-2432    Fax: 508-973-2435

News Archive

MicroRNAs predict heart and kidney health in children without disease

Molecules called microRNAs (miRNAs) that are measurable in urine have been identified by researchers at Mount Sinai as predictors of both heart and kidney health in children without disease.

UofL, Frazier Rehab to establish Spinal Cord Injury Model System

The National Institute on Disability and Rehabilitation Research (NIDRR) of the U.S. Department of Education has awarded researchers at Frazier Rehab Institute and the University of Louisville $2.2 million for five years to establish a Spinal Cord Injury Model System.

Study shows safety, efficacy of intravenous bevacizumab treatment for HHT related bleeding

Intravenous bevacizumab should be considered as a first-line therapy for the treatment of refractory bleeding in patients with severe hereditary hemorrhagic telangiectasia, reports Mayo Clinic Proceedings

Avicena receives orphan drug designation for Huntington's disease

The Avicena Group has announced today that the United States Food and Drug Administration (FDA) has granted orphan drug designation to HD-02, the company's proprietary drug candidate for the treatment of Huntington's disease.

Study elucidates the benefits of Mg supplementation during pregnancy and in hormone-related conditions

RUDN University professor and her colleagues from France proved that higher intake of magnesium and vitamin B6 helps to cope with the consequences of magnesium deficiency during pregnancy and in hormone-related conditions in women.

Read more Medical News

› Verified 6 days ago